These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 9458983)

  • 1. Nosocomial streptococcal blood stream infections in the SCOPE Program: species occurrence and antimicrobial resistance. The SCOPE Hospital Study Group.
    Pfaller MA; Jones RN; Marshall SA; Edmond MB; Wenzel RP
    Diagn Microbiol Infect Dis; 1997 Dec; 29(4):259-63. PubMed ID: 9458983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of cefepime and ceftazidime against 197 nosocomial blood stream isolates of streptococci: a multicenter sample.
    Pfaller MA; Marshall SA; Jones RN
    Diagn Microbiol Infect Dis; 1997 Dec; 29(4):273-6. PubMed ID: 9458985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial susceptibility of viridans group streptococci.
    Tuohy M; Washington JA
    Diagn Microbiol Infect Dis; 1997 Dec; 29(4):277-80. PubMed ID: 9458986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survey of blood stream infections attributable to gram-positive cocci: frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from the SENTRY Antimicrobial Surveillance Program. SENTRY Participants Group.
    Pfaller MA; Jones RN; Doern GV; Sader HS; Kugler KC; Beach ML
    Diagn Microbiol Infect Dis; 1999 Apr; 33(4):283-97. PubMed ID: 10212756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial susceptibility patterns and macrolide resistance genes of viridans group streptococci from blood cultures in Korea.
    Uh Y; Shin DH; Jang IH; Hwang GY; Lee MK; Yoon KJ; Kim HY
    J Antimicrob Chemother; 2004 Jun; 53(6):1095-7. PubMed ID: 15117924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activities of eight macrolide antibiotics and RP-59500 (quinupristin-dalfopristin) against viridans group streptococci isolated from blood of neutropenic cancer patients.
    Alcaide F; Carratala J; Liñares J; Gudiol F; Martin R
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2117-20. PubMed ID: 8878591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a clinical model to predict the presence of β-lactam resistance in viridans group streptococci causing bacteremia in neutropenic cancer patients.
    Shelburne SA; Lasky RE; Sahasrabhojane P; Tarrand JT; Rolston KV
    Clin Infect Dis; 2014 Jul; 59(2):223-30. PubMed ID: 24755857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial susceptibility patterns of beta-hemolytic and viridans group streptococci: report from the SENTRY Antimicrobial Surveillance Program (1997-2000).
    Gordon KA; Beach ML; Biedenbach DJ; Jones RN; Rhomberg PR; Mutnick AH
    Diagn Microbiol Infect Dis; 2002 Jun; 43(2):157-62. PubMed ID: 12088624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of macrolide-lincosamide resistance and multidrug resistance phenotypes in streptococcal isolates causing infections in European hospitals: Evaluation of the in vitro activity of oritavancin and comparator agents.
    Mendes RE; Castanheira M; Farrell DJ; Flamm RK; Sader HS; Jones RN
    J Glob Antimicrob Resist; 2017 Mar; 8():28-32. PubMed ID: 27939809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of macrolide resistance determinants [erm(B) and mef(A)] in Streptococcus pneumoniae and viridans group streptococci (VGS) isolated from adult patients with cystic fibrosis (CF).
    Tazumi A; Maeda Y; Goldsmith CE; Coulter WA; Mason C; Millar BC; McCalmont M; Rendall J; Elborn JS; Matsuda M; Moore JE
    J Antimicrob Chemother; 2009 Sep; 64(3):501-6. PubMed ID: 19584106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythromycin and penicillin resistance mechanisms among viridans group streptococci isolated from blood cultures of adult patients with underlying diseases.
    Ergin A; Eser ÖK; Hasçelik G
    New Microbiol; 2011 Apr; 34(2):187-93. PubMed ID: 21617831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative activity and spectrum of broad-spectrum beta-lactams (cefepime, ceftazidime, ceftriaxone, piperacillin/tazobactam) tested against 12,295 staphylococci and streptococci: report from the SENTRY antimicrobial surveillance program (North America: 2001-2002).
    Fritsche TR; Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2003 Oct; 47(2):435-40. PubMed ID: 14522519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States, I. Study on the threat of emerging resistances: real or perceived? Fluoroquinolone Resistance Surveillance Group.
    Jones RN; Kehrberg EN; Erwin ME; Anderson SC
    Diagn Microbiol Infect Dis; 1994 Aug; 19(4):203-15. PubMed ID: 7851083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High incidence of erythromycin-resistant streptococci in Taiwan.
    Wu JJ; Lin KY; Hsueh PR; Liu JW; Pan HI; Sheu SM
    Antimicrob Agents Chemother; 1997 Apr; 41(4):844-6. PubMed ID: 9087502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial susceptibility of some streptococci strains of anginosus group isolated from oral and maxillofacial infections.
    Băncescu G; Skaug N; Dumitriu S; Băncescu A
    Roum Arch Microbiol Immunol; 1999; 58(1):57-63. PubMed ID: 11845446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of minimum inhibitory concentration by broth microdilution testing versus standard disc diffusion testing in the detection of penicillin, erythromycin and ciprofloxacin resistance in viridans group streptococci.
    Maeda Y; Goldsmith CE; Coulter WA; Mason C; Dooley JSG; Lowery CJ; Millar BC; Moore JE
    J Med Microbiol; 2011 Dec; 60(Pt 12):1782-1786. PubMed ID: 21852527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inducible amp C beta-lactamase producing gram-negative bacilli from blood stream infections: frequency, antimicrobial susceptibility, and molecular epidemiology in a national surveillance program (SCOPE).
    Pfaller MA; Jones RN; Marshall SA; Coffman SL; Hollis RJ; Edmond MB; Wenzel RP
    Diagn Microbiol Infect Dis; 1997 Aug; 28(4):211-9. PubMed ID: 9327251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of selected cephalosporins and erythromycin against staphylococci and pneumococci isolated at 38 North American medical centers participating in the SENTRY Antimicrobial Surveillance Program, 1997-1998.
    Jones RN; Jenkins SG; Hoban DJ; Pfaller MA; Ramphal R
    Diagn Microbiol Infect Dis; 2000 Jun; 37(2):93-8. PubMed ID: 10863103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrolide resistance mechanisms and in vitro susceptibility patterns of viridans group streptococci isolated from blood cultures.
    Ergin A; Ercis S; Hasçelik G
    J Antimicrob Chemother; 2006 Jan; 57(1):139-41. PubMed ID: 16291867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population structure and characterization of viridans group streptococci (VGS) including Streptococcus pneumoniae isolated from adult patients with cystic fibrosis (CF).
    Maeda Y; Elborn JS; Parkins MD; Reihill J; Goldsmith CE; Coulter WA; Mason C; Millar BC; Dooley JS; Lowery CJ; Ennis M; Rendall JC; Moore JE
    J Cyst Fibros; 2011 Mar; 10(2):133-9. PubMed ID: 21145793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.